Good Scientists, Bad Science? How To Respond To 'Renegade' Researchers

Case One: The Molecular biologist who refuses to believe that AIDS is caused by a virus BERKELEY, CALIF.—On a Saturday early in April, as Washington’s famous cherry trees began to blossom, eight of the nation’s top AIDS researchers gathered at George Washington University for a special meeting. But they weren’t there to discuss their latest findings, or to devise new strategies for fighting the deadly disease, or even to enjoy the Washington spring. Instead, says Berke

Written byMarcia Barinaga
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

BERKELEY, CALIF.—On a Saturday early in April, as Washington’s famous cherry trees began to blossom, eight of the nation’s top AIDS researchers gathered at George Washington University for a special meeting. But they weren’t there to discuss their latest findings, or to devise new strategies for fighting the deadly disease, or even to enjoy the Washington spring. Instead, says Berkeley molecular biologist Harry Rubin, one of the participants, “the forum was called to lynch Peter Duesberg.”

That description may be a bit too strong, a bit too bitter. But then, feelings run deep when it comes to Peter Duesberg. As anyone who reads Science or Spin or most newspapers knows by now, the Berkeley biologist has had the temerity not just to challenge the current dogma of AIDS—that the disease is caused by the human immunodeficiency virus—but to do it in a flamboyant and highly public fashion. Duesberg’s stance, argue ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies